Correction to: Efficacy and Safety of Neoadjuvant Subcutaneous Envafolimab in dMMR/MSI-H Locally Advanced Colon Cancer

Target Oncol. 2024 Jul;19(4):663. doi: 10.1007/s11523-024-01077-6.
No abstract available

Publication types

  • Published Erratum